A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGSNet product sales of FILSPARI ...

Celcuity's gedatolisib, a dual PI3K/mTOR inhibitor, shows promise in Phase 3 breast cancer trials. Click here to read an ...

Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGS Net product sales of FILSPARI totaled $50 million in 4Q 2024; $132 million for full yea ...

The move is triggered by the findings of researchers at the Indian Veterinary Research Institute, which undertook a study on ...

Our family moved from Orlando, Florida, to Boston last fall. I’m going stir crazy in the winter weather and want to try hiking. As a native Floridian, I’m ...

[44] Sevoflurane is not associated with hepatotoxicity. Whether the differences in protective effect observed in animals translate into differences in humans was evaluated in a controlled study of ...

The results of most clinical trials with the thistle (Silybum marianum) extract, silymarin, are difficult to interpret because of a variety of reasons: small sample size, variability in type and ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. The field of ...

A New Psychoactive Substance (NPS) is a substance of abuse, either in a pure form or a preparation, that is not controlled by the 1961 Single Convention on Narcotic Drugs or the 1971 Convention on ...